PT977859E - O factor neurotrofico nnt-1 - Google Patents
O factor neurotrofico nnt-1Info
- Publication number
- PT977859E PT977859E PT98906215T PT98906215T PT977859E PT 977859 E PT977859 E PT 977859E PT 98906215 T PT98906215 T PT 98906215T PT 98906215 T PT98906215 T PT 98906215T PT 977859 E PT977859 E PT 977859E
- Authority
- PT
- Portugal
- Prior art keywords
- nnt
- polypeptides
- neurotherapy
- factor
- disclosed
- Prior art date
Links
- 102100029391 Cardiotrophin-like cytokine factor 1 Human genes 0.000 title abstract 4
- 101710107109 Cardiotrophin-like cytokine factor 1 Proteins 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 108010025020 Nerve Growth Factor Proteins 0.000 abstract 1
- 102000007072 Nerve Growth Factors Human genes 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 230000028709 inflammatory response Effects 0.000 abstract 1
- 239000003900 neurotrophic factor Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/792,019 US5741772A (en) | 1997-02-03 | 1997-02-03 | Neurotrophic factor NNT-1 |
| US09/016,534 US6143874A (en) | 1997-02-03 | 1998-01-30 | Antibodies to the neurotrophic factor NNT-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT977859E true PT977859E (pt) | 2004-12-31 |
Family
ID=26688735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98906215T PT977859E (pt) | 1997-02-03 | 1998-02-02 | O factor neurotrofico nnt-1 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0977859B1 (pt) |
| JP (1) | JP2002514067A (pt) |
| CN (1) | CN1195853C (pt) |
| AT (1) | ATE273391T1 (pt) |
| AU (1) | AU718882B2 (pt) |
| CA (1) | CA2279999C (pt) |
| DE (1) | DE69825580T2 (pt) |
| DK (1) | DK0977859T3 (pt) |
| ES (1) | ES2226097T3 (pt) |
| HK (1) | HK1025125A1 (pt) |
| HU (1) | HU225307B1 (pt) |
| IL (2) | IL131103A0 (pt) |
| PT (1) | PT977859E (pt) |
| WO (1) | WO1998033922A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6046035A (en) * | 1997-06-30 | 2000-04-04 | Human Genome Sciences, Inc. | Polynucleotides encoding a cardiotrophin-like cytokine |
| US6800460B1 (en) | 1999-03-11 | 2004-10-05 | Schering Corporation | Mammalian cytokine complexes |
| JP2003500010A (ja) * | 1999-03-11 | 2003-01-07 | シェリング・コーポレーション | 哺乳動物サイトカイン；関連試薬および方法 |
| FR2804436B1 (fr) * | 2000-01-27 | 2002-08-02 | Pf Medicament | PROTEINE DE FUSION scsCNTFR/NNT-1 |
| FR2804434A1 (fr) * | 2000-01-27 | 2001-08-03 | Pf Medicament | Heterocomplexe nnt-1/clf-1 et son utilisation en tant qu'activateur du recepteur complexe cntrfalpha/gp130/lifrbet a |
| FR2804435A1 (fr) * | 2000-01-27 | 2001-08-03 | Pf Medicament | COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha |
| US6849260B2 (en) | 2000-08-18 | 2005-02-01 | Amgen Inc. | Methods and compositions for treating IgE-related disease using NNT-1 inhibitors |
-
1998
- 1998-02-02 ES ES98906215T patent/ES2226097T3/es not_active Expired - Lifetime
- 1998-02-02 JP JP53325898A patent/JP2002514067A/ja active Pending
- 1998-02-02 EP EP98906215A patent/EP0977859B1/en not_active Expired - Lifetime
- 1998-02-02 WO PCT/US1998/002363 patent/WO1998033922A1/en active IP Right Grant
- 1998-02-02 IL IL13110398A patent/IL131103A0/xx not_active IP Right Cessation
- 1998-02-02 CN CNB988036428A patent/CN1195853C/zh not_active Expired - Fee Related
- 1998-02-02 HU HU0001969A patent/HU225307B1/hu not_active IP Right Cessation
- 1998-02-02 IL IL15454398A patent/IL154543A0/xx active IP Right Grant
- 1998-02-02 CA CA002279999A patent/CA2279999C/en not_active Expired - Fee Related
- 1998-02-02 DE DE69825580T patent/DE69825580T2/de not_active Expired - Fee Related
- 1998-02-02 DK DK98906215T patent/DK0977859T3/da active
- 1998-02-02 PT PT98906215T patent/PT977859E/pt unknown
- 1998-02-02 AU AU61495/98A patent/AU718882B2/en not_active Ceased
- 1998-02-02 AT AT98906215T patent/ATE273391T1/de not_active IP Right Cessation
-
2000
- 2000-06-01 HK HK00103324A patent/HK1025125A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69825580T2 (de) | 2005-09-29 |
| HUP0001969A3 (en) | 2002-01-28 |
| DE69825580D1 (de) | 2004-09-16 |
| EP0977859A1 (en) | 2000-02-09 |
| JP2002514067A (ja) | 2002-05-14 |
| CN1195853C (zh) | 2005-04-06 |
| CA2279999C (en) | 2004-07-27 |
| CN1251134A (zh) | 2000-04-19 |
| CA2279999A1 (en) | 1998-08-06 |
| HU225307B1 (en) | 2006-09-28 |
| IL131103A0 (en) | 2001-01-28 |
| AU6149598A (en) | 1998-08-25 |
| HK1025125A1 (en) | 2000-11-03 |
| IL154543A0 (en) | 2003-09-17 |
| EP0977859B1 (en) | 2004-08-11 |
| AU718882B2 (en) | 2000-04-20 |
| ES2226097T3 (es) | 2005-03-16 |
| DK0977859T3 (da) | 2004-12-06 |
| HUP0001969A2 (hu) | 2000-10-28 |
| WO1998033922A1 (en) | 1998-08-06 |
| ATE273391T1 (de) | 2004-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE352626T1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
| ATE323770T1 (de) | Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren | |
| CA2267668A1 (en) | Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide | |
| DK0981630T3 (da) | Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme | |
| WO2000075350A3 (en) | Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use | |
| ATE319818T1 (de) | Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren | |
| DK0917571T3 (da) | Hidtil ukendt agoutirelateret gen | |
| ATE450603T1 (de) | Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren | |
| DE69535696D1 (de) | Tripeptidyl-aminopeptidase | |
| DE69837475D1 (de) | Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren | |
| DK1117798T3 (da) | Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider | |
| ATE315638T1 (de) | Oxalacetat-hydrolase defiziente fungale wirtszellen | |
| PT977859E (pt) | O factor neurotrofico nnt-1 | |
| DE69728415D1 (de) | Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) | |
| WO2000028043A3 (en) | Polypeptides having lactonohydrolase activity and nucleic acids encoding same | |
| AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
| WO2000041509A3 (en) | Polypeptides having acid phosphatase activity and nucleic acids encoding same | |
| ATE288491T1 (de) | Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren | |
| DK0919621T3 (da) | Human TAK1 og DNA der koder derfor | |
| ATE317896T1 (de) | Polypeptide mit glucanotransferase aktivität und dafür kodierende nukleinsäuren | |
| WO2001029084A3 (en) | Novel human proteins and polynucleotides encoding the same | |
| WO2001014534A3 (en) | Polypeptides having pectin acetylesterase activity and nucleic acids encoding same | |
| CA2323506A1 (en) | Mammalian blood loss-induced gene, kd312 | |
| ZA986517B (en) | Production of human mutated proteins in human cells by means of homologous recombination. |